News About: Pharm. Industry
Markets in the treatment of eye disorders are emerging
Ophthalmology is entering one of the most remarkable phases in recent history of this industry; new technologies and treatment modalities for both visual acuity and major eye diseases may dramatically change the compo...
Albumin goes to China
Albumin is to be export to China for the first time as a finished package, Korea Green Cross has announced on Tuesday.
The company is going to export $10 million's worth of albumin within this year and plans to in...
Competition intensifies in Umckamim market
The generic drug market for herbal remedy Umckamim (pelargonium sidoides extract), which have been co-promoted by Yuyu Pharm and Hanwha Pharm, will face fiercer competition as the main patent for Umckamim already expi...
Ilyang’s Supect covered by health insurance
A novel leukemia drug Supect, which was developed by Ilyang Pharm, can be covered by the national health insurance.
The National Health Insurance Corporation decided to get Supect (rodotinib) 800 mg at 64,000 won p...
Lee to head ethical sales divisionLee Byung-man, vice president of Boehringer Ingelheim Korea, has been appointed as a head to lead its ethical sales division, it was learned on June 20.
Lee joined Boehringer...
|
GSK, pharmaceutical wholesalers at odds over distribution margin of Augmentin
GlaxoSmithKline (GSK) and drug wholesalers are on a collision course over GSK's move to lower the distribution margin of an antibiotic Augmentin tablets and syrups to seven percent from the current 10 percent.
Whol...
ODT-based Viagra generics to hit markets
The local generic drug market for Viagrea will face fiercer competition as the Korea Food and Drugs Administration (KFDA) accepted the generic drugs with new orally disintegrating dosage forms, including orally disint...
UBcare buys 60% stake in PlatinumMD
UBcare Co., a leading healthcare solution company in Korea, has struck a strategic partnership with its U.S.-based PlatinumMD.
UBcare said on last Thursday that it has bought a 60 percent stake in PlatinumMD to tak...
Does non-selection of innovative pharmaceutical firms hurt pride of multinational drug companies?
When the government announced a list of 43 innovative pharmaceutical firms including Otsuka Korea on Monday, the KRPIA has expressed its deep regret over the government’s failure to include their other nine candidates...
Twynstar showing robust sales in May
Boehringer Ingelheim’s antihypertensive Twynstar has expand a bigger market share at the brisk pace as its sales in May stood at 4.8 billion won, according to Yakup.com, a pharmaceutical information provider. The drug...
